Inhibitor/Activator
| Cat.No. | Name | Information |
|---|---|---|
| M7727 | CH-223191 | CH-223191 is a potent and specific aryl hydrocarbon receptor (AhR) antagonist. CH-223191 inhibits TCDD-mediated nuclear translocation and DNA binding of AhR, and inhibits TCDD-induced luciferase activity with an IC50 of 0.03 μM. *The compound is unstable in solutions, freshly prepared is recommended |
| M8807 | Perillaldehyde | Perillaldehyde inhibits BaP-induced AHR activation and ROS production, inhibits BaP/AHR-mediated release of the CCL2 chemokine, and activats the NRF2/HO1 antioxidant pathway. |
| M41956 | AHR agonist 4 | AHR agonist 4 is an agonist of Aryl hydrocarbon receptor (AHR), assocaited with the immune balance of Th17/22 and Treg cells. |
| M31143 | Indole-3-ylacetaldehyde | Indole-3-ylacetaldehyde (I3A) |
| M27622 | 1,4-Chrysenequinone | 1,4-Chrysenequinone, a polycyclic aromatic quinone, acts as an activator of aryl hydrocarbon receptor (AhR). |
| M20977 | BAY 2416964 | BAY 2416964 (compound 192) is a potent and orally active antagonist of aryl hydrocarbon receptor (AhR) with IC50 of 341 nM. BAY 2416964 has the potential in the treatment of solid tumors. |
| M20651 | BAY-218 | BAY-218 is a potent and selective small-molecule AhR inhibitor, inhibiting AhR nuclear translocation, dioxin response element (DRE)-luciferase reporter expression and AhR-regulated target gene expression induced by both exogenous and endogenous AhR ligands. |
| M20517 | Minaprine dihydrochloride | activate the aryl hydrocarbon receptor (AhR) signaling pathway |
| M18245 | Brevifolincarboxylic acid | Brevifolincarboxylic acid |
| M18037 | 23-EPI-26-Deoxyactein(27-Deoxyactein) | 23-EPI-26-Deoxyactein(27-Deoxyactein) |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
